Course Overview
Gout Management: Recent Advances 2026 reviews the diagnosis and treatment of gout, with particular attention to difficult-to-treat disease and chronic kidney disease. The agenda includes imaging, urate-lowering therapy, nutritional factors and case-based discussions of refractory gout.
The Columbia University virtual symposium was held on October 16, 2026. It is relevant to rheumatologists, nephrologists, primary care clinicians and other professionals involved in gout care.
Learning Objectives
After attending the original educational program, participants should be better able to:
- Describe current and emerging epidemiologic trends in gout, including factors contributing to increasing disease complexity and comorbidity burden.
- Evaluate contemporary urate-lowering strategies, including treatment targets, optimal timing of therapy, and common gaps between clinical guidelines.
- Explain the mechanisms of action, indications, and safety considerations of biologic therapies used in refractory gout, including appropriate monitoring strategies.
- Apply expert-recommended approaches to complex gout cases, integrating clinical experience with evidence-based treatment guidelines.
- Assess the role of co-therapy and immunomodulation in difficult-to-treat gout, including strategies to optimize treatment efficacy while minimizing adverse effects.
- Integrate gout management principles into the care of patients with advanced chronic kidney disease, balancing therapeutic benefits and risks.
- Analyze treatment-resistant gout cases through interactive clinical discussions to develop practical, patient-centered management plans.
Course Leadership
Jason E. Liebowitz, MD
Course Director — Rheumatology, Columbia University
Adam Mor, MD, PhD
Course Director — Rheumatology, Columbia University
Christine Parsons, MD
Course Director — Rheumatology, Columbia University
Jai Radhakrishnan, MD, MS
Course Director — Nephrology, Columbia University
The course leadership reflects a multidisciplinary emphasis on the relationship between inflammatory arthritis and kidney disease.
Official Faculty
The original event also lists the following speakers:
- Caroline Atlas, MD — Rheumatology, Columbia University
- Gregory Challener, MD — Rheumatology, Columbia University
- Michael H. Pillinger, MD — New York University
- Naomi Schlesinger, MD — University of Utah
- David S. Seres, MD, PhD — Columbia University Medical Center
- Vesh Srivatana, MD — Nephrology, Columbia University
Speaker-specific lecture assignments are not reproduced here because the detailed schedule could not be independently verified.
Topics
Friday, October 16, 2026 (8:55 am to 2:00 pm EST)
-
8:55 am | Welcome
-
Course Directors: Jason Liebowitz, MD; Adam Mor, MD, PhD; Christine Parsons, MD; Jai Radhakrishnan, MD, MS
-
-
9:00 am | Gout in 2026: A Global Perspective
-
Caroline Atlas, MD, Assistant Professor of Medicine, Columbia
-
-
9:30 am | DECT & Ultrasound Imaging in the Diagnosis of Gout
-
Christine Parsons, MD, Assistant Professor of Medicine, Rheumatology, Columbia
-
-
10:00 am | Diet in Gout: How Much Does It Matter?
-
David S. Seres, MD, PhD, Professor of Medicine, Institute of Human Nutrition, Columbia
-
-
10:30 am | Q&A
-
10:45 am | Gout & Cardio-Metabolic Disease
-
Naomi Schlesinger, MD, Professor of Medicine, Rheumatology, University of Utah
-
-
11:15 am | Gout Treatment in 2026: Beyond the ACR Guidelines
-
Michael Pillinger, MD, Professor of Medicine, Biochemistry & Molecular Pharmacology, NYU
-
-
11:45 am | Gout Management in Advanced CKD
-
Vesh Srivatana, MD, Assistant Professor of Medicine, Nephrology, Columbia
-
-
12:15 pm | Novel Agents in the Treatment of Gout
-
Gregory Challener, MD, Assistant Professor of Medicine, Rheumatology, Columbia
-
-
12:45 pm | Interactive Case-Based Panel Discussion
-
Moderators: Adam Mor, MD, PhD; Christine Parsons, MD
-
Panelists: Naomi Schlesinger, MD; Michael Pillinger, MD; Vesh Srivatana, MD
-
-
1:15 pm | Q&A
-
1:30 pm | Non-CME Industry Theatre: KRYSTEXXA: Changing the Course of Uncontrolled Gout
-
Jeff R. Peterson, MD, FACR, Clinical Professor of Medicine, Rheumatology, U. of Washington
-
-
2:00 pm | Adjourn



